SPRINGWORKS THERAPEUTICS INC

CUSIP: 85205L107 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 185,540 Value ($000) $8,719 Avg Close Range
Q1 2025
Shares 50,938 Value ($000) $2,248 Avg Close Range
Q3 2024
Shares 1,961,830 Value ($000) $62,857 Avg Close Range
Q2 2024
Shares 2,333,117 Value ($000) $87,889 Avg Close Range
Q1 2024
Shares 2,966,622 Value ($000) $146,017 Avg Close Range
Q4 2023
Shares 3,024,859 Value ($000) $110,407 Avg Close Range
Q3 2023
Shares 1,288,253 Value ($000) $29,784 Avg Close Range
Q2 2023
Shares 1,207,640 Value ($000) $31,664 Avg Close Range
Q1 2023
Shares 184,334 Value ($000) $4,745 Avg Close Range
Q1 2022
Shares 704,597 Value ($000) $39,768 Avg Close Range
Q4 2021
Shares 407,519 Value ($000) $25,258 Avg Close Range
Q3 2021
Shares 20,893 Value ($000) $1,325 Avg Close Range
Q1 2021
Shares 65,044 Value ($000) $4,785 Avg Close Range